STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 72 filers reported holding STOKE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,045,570 | -63.3% | 265,373 | -1.0% | 0.00% | -100.0% |
| Q2 2023 | $2,850,274 | +73.9% | 268,135 | +36.3% | 0.00% | – |
| Q1 2023 | $1,639,185 | -10.5% | 196,781 | -0.9% | 0.00% | – |
| Q4 2022 | $1,832,303 | -29.9% | 198,516 | -2.6% | 0.00% | -100.0% |
| Q3 2022 | $2,615,000 | -3.8% | 203,715 | -1.0% | 0.00% | 0.0% |
| Q2 2022 | $2,719,000 | -30.8% | 205,801 | +10.3% | 0.00% | 0.0% |
| Q1 2022 | $3,929,000 | -12.1% | 186,635 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $4,472,000 | -6.0% | 186,384 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $4,756,000 | -28.4% | 186,942 | -5.2% | 0.00% | 0.0% |
| Q2 2021 | $6,639,000 | -8.4% | 197,252 | +5.7% | 0.00% | 0.0% |
| Q1 2021 | $7,250,000 | -41.5% | 186,660 | -6.7% | 0.00% | -50.0% |
| Q4 2020 | $12,384,000 | +90.1% | 199,970 | +2.8% | 0.00% | +100.0% |
| Q3 2020 | $6,516,000 | +43.9% | 194,557 | +2.4% | 0.00% | 0.0% |
| Q2 2020 | $4,527,000 | -1.7% | 189,960 | -5.6% | 0.00% | 0.0% |
| Q1 2020 | $4,607,000 | +38.6% | 201,137 | +71.3% | 0.00% | 0.0% |
| Q4 2019 | $3,325,000 | +43.4% | 117,404 | +8.8% | 0.00% | 0.0% |
| Q3 2019 | $2,319,000 | – | 107,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |